Published ahead of print on August 13, 2003, doi:10.1164/rccm.200302-219OC
Am. J. Respir. Crit. Care Med., Volume 168, Number 9, November 2003, 1084-1090
A more recent version of this article appeared on November 1, 2003
Submitted on February 14, 2003
Accepted on August 7, 2003
Prognostic Value of Desaturation During a Six Minute Walk Test In Idiopathic Interstitial Pneumonia
Vibha N Lama1, Kevin R Flaherty1, Galen B Toews1, Thomas V Colby2, William D Travis3, Qi Long4, Susan Murray4, Ella A Kazerooni5, Barry H Gross5, Joseph P Lynch III1, and Fernando J Martinez1*
1 Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI, USA,
2 Pathology, Mayo Clinic, Scottsdale, AZ, USA,
3 Pulmonary and Mediastinal Pathology, Armed Forces Institute of Pathology, Washington, DC, USA,
4 Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA,
5 Radiology, University of Michigan, Ann Arbor, MI, USA
* To whom correspondence should be addressed. E-mail: fmartine{at}umich.edu.
Exercise induced hypoxia is an index of the severity of interstitial lung disease. We hypothesized that desaturation during a six minute walk test would predict mortality for patients with usual interstitial pneumonia (n=83) and non-specific interstitial pneumonia (n=22). Consecutive patients with biopsy-proven disease performed a six minute walk test between 01/96 and 12/2001. Desaturation was defined as a fall in oxygen saturation 88% during the six-minute walk test. Desaturation was common (44/83 usual interstitial pneumonia, 8/22 non-specific interstitial pneumonia; chi-square p=0.39). Patients with usual interstitial pneumonia or non-specific interstitial pneumonia who desaturated had a significantly higher mortality than patients who did not desaturate (respective log-rank tests p=0.0018, p= 0.0089). In patients with usual interstitial pneumonia, the presence of desaturation was associated with an increased hazard of death (hazard ratio 4.2, 95% CI 1.40 - 12.56, p=0.01), after adjusting for age, gender, smoking, baseline diffusion capacity for carbon monoxide, forced vital capacity and resting saturation. We conclude that knowledge of desaturation during a six-minute walk test adds prognostic information for patients with usual interstitial pneumonia and nonspecific interstitial pneumonia.
Key words: usual interstitial pneumonia, non-specific interstitial pneumonia, desaturation
This article has been cited by other articles:

|
 |

|
 |
 
T J Corte, S J Wort, M A Gatzoulis, P Macdonald, D M Hansell, and A U Wells
Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension
Thorax,
October 1, 2009;
64(10):
883 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Swigris, J. Swick, F. S. Wamboldt, D. Sprunger, R. du Bois, A. Fischer, G. P. Cosgrove, S. K. Frankel, E. R. Fernandez-Perez, D. Kervitsky, et al.
Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
Chest,
September 1, 2009;
136(3):
841 - 848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Swigris, X Zhou, F S Wamboldt, R du Bois, R Keith, A Fischer, G P Cosgrove, S K Frankel, D Curran-Everett, and K K Brown
Exercise peripheral oxygen saturation (Spo2) accurately reflects arterial oxygen saturation (Sao2) and predicts mortality in systemic sclerosis
Thorax,
July 1, 2009;
64(7):
626 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells, V. Steen, and G. Valentini
Pulmonary complications: one of the most challenging complications of systemic sclerosis
Rheumatology,
June 1, 2009;
48(suppl_3):
iii40 - iii44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Prasse, C. Probst, E. Bargagli, G. Zissel, G. B. Toews, K. R. Flaherty, M. Olschewski, P. Rottoli, and J. Muller-Quernheim
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
717 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Antoniou, G. Margaritopoulos, F. Economidou, and N. M. Siafakas
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Eur. Respir. J.,
April 1, 2009;
33(4):
882 - 896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Moeller, S. E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P. J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, et al.
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 1, 2009;
179(7):
588 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Fell, L. X. Liu, C. Motika, E. A. Kazerooni, B. H. Gross, W. D. Travis, T. V. Colby, S. Murray, G. B. Toews, F. J. Martinez, et al.
The Prognostic Value of Cardiopulmonary Exercise Testing in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
March 1, 2009;
179(5):
402 - 407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kreider and R. M. Kotloff
Selection of Candidates for Lung Transplantation
Proceedings of the ATS,
January 15, 2009;
6(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Idiopathic Pulmonary Fibrosis, Nonspecific Interstitial Pneumonia/Fibrosis, and Sarcoidosis
ACCP Pulmonary Med Brd Rev,
January 1, 2009;
25(0):
635 - 686.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kim and K. C. Meyer
Review: Therapies for interstitial lung disease: past, present and future
Therapeutic Advances in Respiratory Disease,
October 1, 2008;
2(5):
319 - 338.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casanova, C. Cote, J. M. Marin, V. Pinto-Plata, J. P. de Torres, A. Aguirre-Jaime, C. Vassaux, and B. R. Celli
Distance and Oxygen Desaturation During the 6-min Walk Test as Predictors of Long-term Mortality in Patients With COPD
Chest,
October 1, 2008;
134(4):
746 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Shin, K. S. Lee, M. P. Chung, J. Han, Y. A Bae, T. S. Kim, and M. J. Chung
Prognostic Determinants among Clinical, Thin-Section CT, and Histopathologic Findings for Fibrotic Idiopathic Interstitial Pneumonias: Tertiary Hospital Study
Radiology,
October 1, 2008;
249(1):
328 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax,
September 1, 2008;
63(Suppl_5):
v1 - v58.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Bourbonnais and L. Samavati
Clinical predictors of pulmonary hypertension in sarcoidosis
Eur. Respir. J.,
August 1, 2008;
32(2):
296 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Han, S. Murray, C. D. Fell, K. R. Flaherty, G. B. Toews, J. Myers, T. V. Colby, W. D. Travis, E. A. Kazerooni, B. H. Gross, et al.
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Eur. Respir. J.,
June 1, 2008;
31(6):
1183 - 1188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Strange and J. R. Seibold
Scleroderma Lung Disease: "If You Don't Know Where You Are Going, Any Road Will Take You There"
Am. J. Respir. Crit. Care Med.,
June 1, 2008;
177(11):
1178 - 1179.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A E Holland, C J Hill, M Conron, P Munro, and C F McDonald
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease
Thorax,
June 1, 2008;
63(6):
549 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Giannakoulas, T. D. Karamitsos, G. Pitsiou, and H. I. Karvounis
Right ventricular dysfunction and functional limitation in idiopathic pulmonary fibrosis
Eur. Respir. J.,
January 1, 2008;
31(1):
219 - 220.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation,
December 18, 2007;
116(25):
2992 - 3005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Zisman, A. S. Karlamangla, D. J. Ross, M. P. Keane, J. A. Belperio, R. Saggar, J. P. Lynch III, A. Ardehali, and J. Goldin
High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest,
September 1, 2007;
132(3):
773 - 779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2007;
132(2):
637 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Baughman, B. K. Sparkman, and E. E. Lower
Six-Minute Walk Test and Health Status Assessment in Sarcoidosis
Chest,
July 1, 2007;
132(1):
207 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, A.-C. Andrei, T. E. King Jr., G. Raghu, T. V. Colby, A. Wells, N. Bassily, K. Brown, R. du Bois, A. Flint, et al.
Idiopathic Interstitial Pneumonia: Do Community and Academic Physicians Agree on Diagnosis?
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
1054 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan, P. W. Noble, and R. M. Tuder
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Am. J. Respir. Crit. Care Med.,
May 1, 2007;
175(9):
875 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2006
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
655 - 660.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Fell and F. J. Martinez
The Impact of Pulmonary Arterial Hypertension on Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2007;
131(3):
641 - 643.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hamada, S. Nagai, S. Tanaka, T. Handa, M. Shigematsu, T. Nagao, M. Mishima, M. Kitaichi, and T. Izumi
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2007;
131(3):
650 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dal Corso, S. R. Duarte, J. A. Neder, C. Malaguti, M. B. de Fuccio, C. A. de Castro Pereira, and L. E. Nery
A step test to assess exercise-related oxygen desaturation in interstitial lung disease
Eur. Respir. J.,
February 1, 2007;
29(2):
330 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al.
Recommendations on the use of exercise testing in clinical practice
Eur. Respir. J.,
January 1, 2007;
29(1):
185 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. O. Villalba, P. D. Sampaio-Barros, M. C. Pereira, E. M. F. P. Cerqueira, C. A. Leme Jr, J. F. Marques-Neto, and I. A. Paschoal
Six-Minute Walk Test for the Evaluation of Pulmonary Disease Severity in Scleroderma Patients
Chest,
January 1, 2007;
131(1):
217 - 222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O.J. Dempsey, K.M. Kerr, L. Gomersall, H. Remmen, and G.P. Currie
Idiopathic pulmonary fibrosis: an update
QJM,
October 1, 2006;
99(10):
643 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, A.-C. Andrei, S. Murray, C. Fraley, T. V. Colby, W. D. Travis, V. Lama, E. A. Kazerooni, B. H. Gross, G. B. Toews, et al.
Idiopathic Pulmonary Fibrosis: Prognostic Value of Changes in Physiology and Six-Minute-Walk Test
Am. J. Respir. Crit. Care Med.,
October 1, 2006;
174(7):
803 - 809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lederer, S. M. Arcasoy, J. S. Wilt, F. D'Ovidio, J. R. Sonett, and S. M. Kawut
Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
September 15, 2006;
174(6):
659 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Croxton, W. C. Bailey, and for the NHLBI Working Group on Long-term Oxygen Tr
Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research: An NHLBI Workshop Report
Am. J. Respir. Crit. Care Med.,
August 15, 2006;
174(4):
373 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1066 - 1071.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Lettieri, S. D. Nathan, S. D. Barnett, S. Ahmad, and A. F. Shorr
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Chest,
March 1, 2006;
129(3):
746 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu, S. T.-Y. Yang, C. Spada, J. Hayes, and C. A. Pellegrini
Sole Treatment of Acid Gastroesophageal Reflux in Idiopathic Pulmonary Fibrosis: A Case Series
Chest,
March 1, 2006;
129(3):
794 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez
Idiopathic Interstitial Pneumonias: Usual Interstitial Pneumonia versus Nonspecific Interstitial Pneumonia.
Proceedings of the ATS,
January 1, 2006;
3(1):
81 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Kim, H. R. Collard, and T. E. King Jr.
Classification and natural history of the idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
285 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and K. Flaherty
Pulmonary function testing in idiopathic interstitial pneumonias.
Proceedings of the ATS,
January 1, 2006;
3(4):
315 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, H. M. Jansen, W. MacNee, M. Thomeer, B. Wallaert, F. Laurent, et al.
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis.
N. Engl. J. Med.,
November 24, 2005;
353(21):
2229 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Johnson and G. Raghu
Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures
Eur. Respir. J.,
November 1, 2005;
26(5):
755 - 758.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu
Poor Choice of Primary Outcome in a Clinical Trial of Pirfenidone in Patients with IPF
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1229 - 1230.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan
Therapeutic Intervention: Assessing the Role of the International Consensus Guidelines
Chest,
November 1, 2005;
128(5_suppl_1):
533S - 539S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Noble, L. Tanoue, and R. Homer
Case Study Review
Chest,
November 1, 2005;
128(5_suppl_1):
540S - 546S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Strange
Treatment for Secondary Pulmonary Hypertension
Chest,
October 1, 2005;
128(4):
1897 - 1898.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eaton, P. Young, D. Milne, and A. U. Wells
Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
May 15, 2005;
171(10):
1150 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. du Bois
Is Idiopathic Pulmonary Fibrosis Now Treatable?
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
939 - 940.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Azuma, T. Nukiwa, E. Tsuboi, M. Suga, S. Abe, K. Nakata, Y. Taguchi, S. Nagai, H. Itoh, M. Ohi, et al.
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
May 1, 2005;
171(9):
1040 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Egan, F J Martinez, A U Wells, and T Williams
Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification
Thorax,
April 1, 2005;
60(4):
270 - 273.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jegal, D. S. Kim, T. S. Shim, C.-M. Lim, S. Do Lee, Y. Koh, W. S. Kim, W. D. Kim, J. S. Lee, W. D. Travis, et al.
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
639 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan
Lung Transplantation: Disease-Specific Considerations for Referral
Chest,
March 1, 2005;
127(3):
1006 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Eur. Respir. J.,
January 1, 2005;
25(1):
96 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Swigris, W. G. Kuschner, J. L. Kelsey, and M. K. Gould
Idiopathic Pulmonary Fibrosis: Challenges and Opportunities for the Clinician and Investigator
Chest,
January 1, 2005;
127(1):
275 - 283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Flaherty, T. E. King Jr., G. Raghu, J. P. Lynch III, T. V. Colby, W. D. Travis, B. H. Gross, E. A. Kazerooni, G. B. Toews, Q. Long, et al.
Idiopathic Interstitial Pneumonia: What Is the Effect of a Multidisciplinary Approach to Diagnosis?
Am. J. Respir. Crit. Care Med.,
October 15, 2004;
170(8):
904 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
288 - 300.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|